| dc.contributor.author | Ergün, Yakup | |
| dc.contributor.author | Esen, Selin Aktürk | |
| dc.contributor.author | Uçar, Gökhan | |
| dc.contributor.author | Açıkgöz, Yusuf | |
| dc.contributor.author | Karaçin, Cengiz | |
| dc.date.accessioned | 2022-12-06T13:23:00Z | |
| dc.date.available | 2022-12-06T13:23:00Z | |
| dc.date.issued | 2021 | en_US |
| dc.identifier.citation | Ergun, Y., Esen, S. A., Ucar, G., Acikgoz, Y., & Karacin, C. (2021). Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic?. JCO oncology practice, 17(7), 455–456. https://doi.org/10.1200/OP.20.01091 | en_US |
| dc.identifier.issn | 2688-1527 | |
| dc.identifier.uri | https://doi.org/10.1200/OP.20.01091 | |
| dc.identifier.uri | https://hdl.handle.net/11436/7228 | |
| dc.description.abstract | ..... | en_US |
| dc.description.abstract | ..... | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Lippincott Williams & Wilkins | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Is it safe to use long-acting G-CSF for febrile neutropenia prophylaxis in COVID-19 pandemic? | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.contributor.institutionauthor | Karaçin, Cengiz | |
| dc.identifier.doi | 10.1200/OP.20.01091 | en_US |
| dc.identifier.volume | 17 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.startpage | 455 | en_US |
| dc.identifier.endpage | 456 | en_US |
| dc.relation.journal | JCO Oncology Practice | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
